| Biotricity is a medical technology company focused on biometric data monitoring solutions. Co. delivers remote monitoring solutions to the medical, healthcare, and consumer markets, with a focus on diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. Co.'s Bioflux is an integrated electrocardiogram device and software solution for the mobile cardiac telemetry market. The Bioflux platform has a built-in cellular chipset and a real-time embedded operating system which allows for Co.'s technology to be utilized as an Internet of Things platform. This technology can be utilized into other applications and industries by utilizing the platform and OS side of Bioflux. We show 3 historical shares outstanding datapoints in our BTCY shares outstanding history coverage, used to compute BTCY market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing BTCY market cap history over the course of time is important for investors
interested in comparing BTCY's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of BTCY versus a peer is one thing; comparing
BTCY market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like BTCY can fluctuate over the course of history.
With this page we aim to empower investors researching BTCY by allowing them to research the BTCY market cap history.